Table of Contents Chapter 1 Overview of Antiemetics 1.1 Definition of Antiemetics in This Report 1.2 Commercial Types of Antiemetics 1.2.1 Phenothiazine Drugs 1.2.2 Antihistamine Drug 1.2.3 Anticholinergic Drugs 1.3 Downstream Application of Antiemetics 1.3.1 Hospital 1.3.2 Medical Center 1.3.3 Clinic 1.4 Development History of Antiemetics 1.5 Market Status and Trend of Antiemetics 2013-2023 1.5.1 Global Antiemetics Market Status and Trend 2013-2023 1.5.2 Regional Antiemetics Market Status and Trend 2013-2023 Chapter 2 Global Market Status and Forecast by Regions 2.1 Market Development of Antiemetics 2013-2017 2.2 Sales Market of Antiemetics by Regions 2.2.1 Sales Volume of Antiemetics by Regions 2.2.2 Sales Value of Antiemetics by Regions 2.3 Production Market of Antiemetics by Regions 2.4 Global Market Forecast of Antiemetics 2018-2023 2.4.1 Global Market Forecast of Antiemetics 2018-2023 2.4.2 Market Forecast of Antiemetics by Regions 2018-2023 Chapter 3 Global Market Status and Forecast by Types 3.1 Sales Volume of Antiemetics by Types 3.2 Sales Value of Antiemetics by Types 3.3 Market Forecast of Antiemetics by Types Chapter 4 Global Market Status and Forecast by Downstream Industry 4.1 Global Sales Volume of Antiemetics by Downstream Industry 4.2 Global Market Forecast of Antiemetics by Downstream Industry Chapter 5 North America Market Status by Countries, Type, Manufacturers and Downstream Industry 5.1 North America Antiemetics Market Status by Countries 5.1.1 North America Antiemetics Sales by Countries (2013-2017) 5.1.2 North America Antiemetics Revenue by Countries (2013-2017) 5.1.3 United States Antiemetics Market Status (2013-2017) 5.1.4 Canada Antiemetics Market Status (2013-2017) 5.1.5 Mexico Antiemetics Market Status (2013-2017) 5.2 North America Antiemetics Market Status by Manufacturers 5.3 North America Antiemetics Market Status by Type (2013-2017) 5.3.1 North America Antiemetics Sales by Type (2013-2017) 5.3.2 North America Antiemetics Revenue by Type (2013-2017) 5.4 North America Antiemetics Market Status by Downstream Industry (2013-2017) Chapter 6 Europe Market Status by Countries, Type, Manufacturers and Downstream Industry 6.1 Europe Antiemetics Market Status by Countries 6.1.1 Europe Antiemetics Sales by Countries (2013-2017) 6.1.2 Europe Antiemetics Revenue by Countries (2013-2017) 6.1.3 Germany Antiemetics Market Status (2013-2017) 6.1.4 UK Antiemetics Market Status (2013-2017) 6.1.5 France Antiemetics Market Status (2013-2017) 6.1.6 Italy Antiemetics Market Status (2013-2017) 6.1.7 Russia Antiemetics Market Status (2013-2017) 6.1.8 Spain Antiemetics Market Status (2013-2017) 6.1.9 Benelux Antiemetics Market Status (2013-2017) 6.2 Europe Antiemetics Market Status by Manufacturers 6.3 Europe Antiemetics Market Status by Type (2013-2017) 6.3.1 Europe Antiemetics Sales by Type (2013-2017) 6.3.2 Europe Antiemetics Revenue by Type (2013-2017) 6.4 Europe Antiemetics Market Status by Downstream Industry (2013-2017) Chapter 7 Asia Pacific Market Status by Countries, Type, Manufacturers and Downstream Industry 7.1 Asia Pacific Antiemetics Market Status by Countries 7.1.1 Asia Pacific Antiemetics Sales by Countries (2013-2017) 7.1.2 Asia Pacific Antiemetics Revenue by Countries (2013-2017) 7.1.3 China Antiemetics Market Status (2013-2017) 7.1.4 Japan Antiemetics Market Status (2013-2017) 7.1.5 India Antiemetics Market Status (2013-2017) 7.1.6 Southeast Asia Antiemetics Market Status (2013-2017) 7.1.7 Australia Antiemetics Market Status (2013-2017) 7.2 Asia Pacific Antiemetics Market Status by Manufacturers 7.3 Asia Pacific Antiemetics Market Status by Type (2013-2017) 7.3.1 Asia Pacific Antiemetics Sales by Type (2013-2017) 7.3.2 Asia Pacific Antiemetics Revenue by Type (2013-2017) 7.4 Asia Pacific Antiemetics Market Status by Downstream Industry (2013-2017) Chapter 8 Latin America Market Status by Countries, Type, Manufacturers and Downstream Industry 8.1 Latin America Antiemetics Market Status by Countries 8.1.1 Latin America Antiemetics Sales by Countries (2013-2017) 8.1.2 Latin America Antiemetics Revenue by Countries (2013-2017) 8.1.3 Brazil Antiemetics Market Status (2013-2017) 8.1.4 Argentina Antiemetics Market Status (2013-2017) 8.1.5 Colombia Antiemetics Market Status (2013-2017) 8.2 Latin America Antiemetics Market Status by Manufacturers 8.3 Latin America Antiemetics Market Status by Type (2013-2017) 8.3.1 Latin America Antiemetics Sales by Type (2013-2017) 8.3.2 Latin America Antiemetics Revenue by Type (2013-2017) 8.4 Latin America Antiemetics Market Status by Downstream Industry (2013-2017) Chapter 9 Middle East and Africa Market Status by Countries, Type, Manufacturers and Downstream Industry 9.1 Middle East and Africa Antiemetics Market Status by Countries 9.1.1 Middle East and Africa Antiemetics Sales by Countries (2013-2017) 9.1.2 Middle East and Africa Antiemetics Revenue by Countries (2013-2017) 9.1.3 Middle East Antiemetics Market Status (2013-2017) 9.1.4 Africa Antiemetics Market Status (2013-2017) 9.2 Middle East and Africa Antiemetics Market Status by Manufacturers 9.3 Middle East and Africa Antiemetics Market Status by Type (2013-2017) 9.3.1 Middle East and Africa Antiemetics Sales by Type (2013-2017) 9.3.2 Middle East and Africa Antiemetics Revenue by Type (2013-2017) 9.4 Middle East and Africa Antiemetics Market Status by Downstream Industry (2013-2017) Chapter 10 Market Driving Factor Analysis of Antiemetics 10.1 Global Economy Situation and Trend Overview 10.2 Antiemetics Downstream Industry Situation and Trend Overview Chapter 11 Antiemetics Market Competition Status by Major Manufacturers 11.1 Production Volume of Antiemetics by Major Manufacturers 11.2 Production Value of Antiemetics by Major Manufacturers 11.3 Basic Information of Antiemetics by Major Manufacturers 11.3.1 Headquarters Location and Established Time of Antiemetics Major Manufacturer 11.3.2 Employees and Revenue Level of Antiemetics Major Manufacturer 11.4 Market Competition News and Trend 11.4.1 Merger, Consolidation or Acquisition News 11.4.2 Investment or Disinvestment News 11.4.3 New Product Development and Launch Chapter 12 Antiemetics Major Manufacturers Introduction and Market Data 12.1 B.Braun 12.1.1 Company profile 12.1.2 Representative Antiemetics Product 12.1.3 Antiemetics Sales, Revenue, Price and Gross Margin of B.Braun 12.2 Eisai 12.2.1 Company profile 12.2.2 Representative Antiemetics Product 12.2.3 Antiemetics Sales, Revenue, Price and Gross Margin of Eisai 12.3 SRS Pharmaceuticals 12.3.1 Company profile 12.3.2 Representative Antiemetics Product 12.3.3 Antiemetics Sales, Revenue, Price and Gross Margin of SRS Pharmaceuticals 12.4 Mirabilia Sciences Pvt 12.4.1 Company profile 12.4.2 Representative Antiemetics Product 12.4.3 Antiemetics Sales, Revenue, Price and Gross Margin of Mirabilia Sciences Pvt 12.5 Pfizer 12.5.1 Company profile 12.5.2 Representative Antiemetics Product 12.5.3 Antiemetics Sales, Revenue, Price and Gross Margin of Pfizer 12.6 Merck 12.6.1 Company profile 12.6.2 Representative Antiemetics Product 12.6.3 Antiemetics Sales, Revenue, Price and Gross Margin of Merck 12.7 Sanofi 12.7.1 Company profile 12.7.2 Representative Antiemetics Product 12.7.3 Antiemetics Sales, Revenue, Price and Gross Margin of Sanofi Chapter 13 Upstream and Downstream Market Analysis of Antiemetics 13.1 Industry Chain of Antiemetics 13.2 Upstream Market and Representative Companies Analysis 13.3 Downstream Market and Representative Companies Analysis Chapter 14 Cost and Gross Margin Analysis of Antiemetics 14.1 Cost Structure Analysis of Antiemetics 14.2 Raw Materials Cost Analysis of Antiemetics 14.3 Labor Cost Analysis of Antiemetics 14.4 Manufacturing Expenses Analysis of Antiemetics Chapter 15 Report Conclusion Chapter 16 Research Methodology and Reference 16.1 Methodology/Research Approach 16.1.1 Research Programs/Design 16.1.2 Market Size Estimation 16.1.3 Market Breakdown and Data Triangulation 16.2 Data Source 16.2.1 Secondary Sources 16.2.2 Primary Sources 16.3 Reference

List of Tables Table Advantage and Disadvantage of Phenothiazine Drugs Table Advantage and Disadvantage of Antihistamine Drug Table Advantage and Disadvantage of Anticholinergic Drugs Table Sales Volume of Antiemetics by Regions 2013-2017 Table Sales Value of Antiemetics by Regions 2013-2017 Table Production Volume of Antiemetics by Regions 2013-2017 Table Global Sales Volume of Antiemetics by Regions 2018-2023 Table Global Sales Value of Antiemetics by Regions 2018-2023 Table Global Production Volume of Antiemetics by Regions 2018-2023 Table Sales Volume of Antiemetics by Types 2013-2017 Table Sales Value of Antiemetics by Types 2013-2017 Table Sales Volume Forecast of Antiemetics by Types 2018-2023 Table Sales Value Forecast of Antiemetics by Types 2018-2023 Table Sales Volume of Antiemetics by Downstream Industry 2013-2017 Table Sales Volume Forecast of Antiemetics by Downstream Industry 2018-2023 Table North America Antiemetics Sales by Countries (2013-2017) Table North America Antiemetics Sales Share by Countries (2013-2017) Table North America Antiemetics Revenue by Countries (2013-2017) Table North America Antiemetics Revenue Market Share by Countries (2013-2017) Table North America Antiemetics Sales by Type (2013-2017) Table North America Antiemetics Sales Share by Type (2013-2017) Table North America Antiemetics Revenue by Type (2013-2017) Table North America Antiemetics Revenue Share by Type (2013-2017) Table North America Antiemetics Sales by Downstream Industry (2013-2017) Table North America Antiemetics Sales Share by Downstream Industry (2013-2017) Table Europe Antiemetics Sales by Countries (2013-2017) Table Europe Antiemetics Sales Share by Countries (2013-2017) Table Europe Antiemetics Revenue by Countries (2013-2017) Table Europe Antiemetics Revenue Market Share by Countries (2013-2017) Table Europe Antiemetics Sales by Type (2013-2017) Table Europe Antiemetics Sales Share by Type (2013-2017) Table Europe Antiemetics Revenue by Type (2013-2017) Table Europe Antiemetics Revenue Share by Type (2013-2017) Table Europe Antiemetics Sales by Downstream Industry (2013-2017) Table Europe Antiemetics Sales Share by Downstream Industry (2013-2017) Table Asia Pacific Antiemetics Sales by Countries (2013-2017) Table Asia Pacific Antiemetics Sales Share by Countries (2013-2017) Table Asia Pacific Antiemetics Revenue by Countries (2013-2017) Table Asia Pacific Antiemetics Revenue Market Share by Countries (2013-2017) Table Asia Pacific Antiemetics Sales by Type (2013-2017) Table Asia Pacific Antiemetics Sales Share by Type (2013-2017) Table Asia Pacific Antiemetics Revenue by Type (2013-2017) Table Asia Pacific Antiemetics Revenue Share by Type (2013-2017) Table Asia Pacific Antiemetics Sales by Downstream Industry (2013-2017) Table Asia Pacific Antiemetics Sales Share by Downstream Industry (2013-2017) Table Latin America Antiemetics Sales by Countries (2013-2017) Table Latin America Antiemetics Sales Share by Countries (2013-2017) Table Latin America Antiemetics Revenue by Countries (2013-2017) Table Latin America Antiemetics Revenue Market Share by Countries (2013-2017) Table Latin America Antiemetics Sales by Type (2013-2017) Table Latin America Antiemetics Sales Share by Type (2013-2017) Table Latin America Antiemetics Revenue by Type (2013-2017) Table Latin America Antiemetics Revenue Share by Type (2013-2017) Table Latin America Antiemetics Sales by Downstream Industry (2013-2017) Table Latin America Antiemetics Sales Share by Downstream Industry (2013-2017) Table Middle East and Africa Antiemetics Sales by Regions (2013-2017) Table Middle East and Africa Antiemetics Sales Share by Regions (2013-2017) Table Middle East and Africa Antiemetics Revenue by Regions (2013-2017) Table Middle East and Africa Antiemetics Revenue Market Share by Regions (2013-2017) Table Middle East and Africa Antiemetics Sales by Type (2013-2017) Table Middle East and Africa Antiemetics Sales Share by Type (2013-2017) Table Middle East and Africa Antiemetics Revenue by Type (2013-2017) Table Middle East and Africa Antiemetics Revenue Share by Type (2013-2017) Table Middle East and Africa Antiemetics Sales by Downstream Industry (2013-2017) Table Middle East and Africa Antiemetics Sales Share by Downstream Industry (2013-2017) Table Production Volume of Antiemetics by Major Manufacturers 2013-2017 Table Production Value of Antiemetics by Major Manufacturers 2013-2017 Table Headquarters Location and Established Time of Antiemetics Major Manufacturer Table Employees and Revenue Level of Antiemetics Major Manufacturer Table Representative Antiemetics Product One of B.Braun Table Representative Antiemetics Product Two of B.Braun Table Antiemetics Sales, Revenue, Price and Gross Margin of B.Braun 2013-2017 Table Representative Antiemetics Product One of Eisai Table Representative Antiemetics Product Two of Eisai Table Antiemetics Sales, Revenue, Price and Gross Margin of Eisai 2013-2017 Table Representative Antiemetics Product One of SRS Pharmaceuticals Table Representative Antiemetics Product Two of SRS Pharmaceuticals Table Antiemetics Sales, Revenue, Price and Gross Margin of SRS Pharmaceuticals 2013-2017 Table Representative Antiemetics Product One of Mirabilia Sciences Pvt Table Representative Antiemetics Product Two of Mirabilia Sciences Pvt Table Antiemetics Sales, Revenue, Price and Gross Margin of Mirabilia Sciences Pvt 2013-2017 Table Representative Antiemetics Product One of Pfizer Table Representative Antiemetics Product Two of Pfizer Table Antiemetics Sales, Revenue, Price and Gross Margin of Pfizer 2013-2017 Table Representative Antiemetics Product One of Merck Table Representative Antiemetics Product Two of Merck Table Antiemetics Sales, Revenue, Price and Gross Margin of Merck 2013-2017 Table Representative Antiemetics Product One of Sanofi Table Representative Antiemetics Product Two of Sanofi Table Antiemetics Sales, Revenue, Price and Gross Margin of Sanofi 2013-2017